TrialCancer medicine2019

Fixed combination of oral NEPA (netupitant-palonosetron) for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in patients receiving multiple cycles of chemotherapy: Efficacy data from 2 randomized, double-blind phase III studies.

Lee Schwartzberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.